![Harold E. van Wart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Harold E. van Wart
Directeur/Membre du Conseil chez Idun Pharmaceuticals, Inc.
Postes actifs de Harold E. van Wart
Sociétés | Poste | Début | Fin |
---|---|---|---|
Idun Pharmaceuticals, Inc.
![]() Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Harold E. van Wart
Anciens postes connus de Harold E. van Wart
Sociétés | Poste | Début | Fin |
---|---|---|---|
CYMABAY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2003 | 01/01/2017 |
Directeur Général | 01/01/2003 | 29/03/2017 | |
Directeur des opérations | 01/12/2001 | 01/01/2003 | |
Directeur Technique/Scientifique/R&D | 01/10/2000 | 01/12/2002 | |
President | 01/01/2001 | 29/03/2017 | |
The Bay Area Bioscience Association | Directeur/Membre du Conseil | - | - |
Président | - | 26/12/2014 | |
Syntex Corp. | Corporate Officer/Principal | 01/01/1992 | 01/01/2000 |
Florida State University | Corporate Officer/Principal | 01/01/1978 | 01/01/1992 |
California Biomedical Innovation Alliance
![]() California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Président | - | - |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - | - |
HISTOGEN INC. | Directeur/Membre du Conseil | 01/03/2007 | - |
Independent Dir/Board Member | 01/03/2007 | - |
Formation de Harold E. van Wart
Cornell University | Doctorate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 2 |
Chairman | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 7 |
---|---|
CymaBay Therapeutics, Inc.
![]() CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Conatus Pharmaceuticals, Inc.
![]() Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
The Bay Area Bioscience Association | Health Technology |
Idun Pharmaceuticals, Inc.
![]() Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
Syntex Corp. | Health Technology |
California Biomedical Innovation Alliance
![]() California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Health Technology |
- Bourse
- Insiders
- Harold E. van Wart
- Expérience